mixsiter.ru


Bristol Myers Stock Forecast

The current price of BMY is USD — it has increased by % in the past 24 hours. Watch Bristol-Myers Squibb Company stock price performance more closely. BMY's current price target is $ Learn why top analysts are making this stock forecast for Bristol-Myers Squibb at MarketBeat. Bristol Myers Squibb Co. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - The 15 analysts with month price forecasts for BMY stock have an average target of , with a low estimate of 42 and a high estimate of The average. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products.

Get the latest Bristol-Myers Squibb (BMY) stock forecast for tomorrow and next week. Stay ahead of the game with our Bristol-Myers Squibb stock price. Bristol-Myers Squibb Stock Forecast · Over the next 52 weeks, Bristol-Myers Squibb has on average historically risen by % based on the past 52 years of stock. HOLD on weak near-term outlook. Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and. BMY Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Trading at good value compared to. Analyst Price Targets ; Low ; Average ; Current ; High. According to analysts, BMY price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ BMY will report FY earnings on 02/06/ Yearly Estimates. Stock Price Target BMY ; High · ; Median · ; Low · ; Average · ; Current Price · The average stock forecast for Bristol-Myers Squibb Co (BMY) is USD. This price target corresponds to an upside of %. The range of stock forecasts. Bristol-Myers Squibb Co BMY:NYSE · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date08/29/23 · 52 Week Low On average, Wall Street analysts predict that Bristol Myers Squibb Co's share price could fall to $ by Aug 22, The average Bristol Myers Squibb Co.

Bristol-Myers Squibb's revenue is forecast to decline at % per annum while its annual earnings are expected to grow at % per year. EPS is expected to. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. BMY will report earnings. Bristol-Myers Squibb (BMY) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. The average price target is $ with a high estimate of $62 and a low estimate of $ Stock analysis for Bristol-Myers Squibb Co (BMY:New York) including stock price, stock chart, company news, key statistics, fundamentals and company. View Bristol-Myers Squibb Company BMY stock quote prices, financial information, real-time forecasts, and company news from CNN. BMY | Complete Bristol Myers Squibb Co. stock news by MarketWatch. View Bristol Myers price target raised to $42 from $41 at Barclays. Aug. 22, We are holding steady to our $63 Bristol-Myers fair value estimate following second-quarter results that ran above our expectations.

Bristol-Myers Squibb Co has a consensus price target of $ based on the ratings of 28 analysts. The high is $90 issued by Citigroup on May 26, The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals. The Bristol-Myers Squibb stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term. According to 17 analysts, the average rating for BMY stock is "Hold." The month stock price forecast is $, which is an increase of % from the latest.

The stock price for Bristol-Myers Squibb (NYSE: BMY) is $ last updated August 28, at PM EDT. Q. Does Bristol-Myers Squibb (BMY) pay a dividend? A. Over the last 12 months, its price fell by percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at by the end of this quarter and. Bristol-Myers Squibb (BMY) stock price prediction is USD. The Bristol-Myers Squibb stock forecast is USD for August Analyst Carter Gould revised BMY's rating to Underweight while upholding the price target at $41, potentially impacting the downtrend. The mixed analyst. Get the latest Bristol-Myers Squibb Company (BMY) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. The average one-year price target for Bristol-Myers Squibb Company is $ The forecasts range from a low of $ to a high of $

Car Insurance 1 Year Price | Pros And Cons Of Tesla Powerwall

37 38 39 40 41

Copyright 2019-2024 Privice Policy Contacts SiteMap RSS